Synopsis:
Kwality Prescription drugs Restricted, a Pharma Inventory, stories 23.35% YoY income progress and a 67.10% YoY internet revenue surge in Q2 FY26 outcomes.
This Pharma Inventory, engaged within the manufacture and export of advanced pharmaceutical molecules and completed formulations, together with generics, cephalosporins, beta-lactams, oncology, and biologics, jumped 15 % after the corporate reported September quarterly outcomes with a 67.10 % YoY enhance in internet revenue.
With a market capitalization of Rs. 1,021.48 crores, the share of Kwality Prescription drugs Restricted has reached an intraday excessive of Rs. 1010.45 per fairness share, rising almost 14.67 % from its earlier day’s shut value of Rs. 881.15. Since then, the inventory has retreated and is at the moment buying and selling at Rs. 984.45 per fairness share.
Q2 FY26 Outcome Walkthrough
Coming into the quarterly outcomes of Kwality Prescription drugs Restricted, the corporate’s consolidated income from operations elevated by 23.35 % YOY, from Rs. 90.03 crore in Q2 FY25 to Rs. 111.05 crore in Q2 FY26, and decreased barely by 0.39 % QoQ from Rs. 111.48 crore in Q1 FY26.
In Q2 FY26, Kwality Prescription drugs Restricted’s consolidated internet revenue elevated by 67.10 % YOY, reaching Rs. 14.12 crore in comparison with Rs. 8.45 crore throughout the identical interval final yr. As in comparison with Q1 FY26, the online revenue has elevated by 18.56 %, from Rs. 11.91 crore. The essential earnings per share elevated by 66.87 % and stood at Rs. 13.60 as towards Rs. 8.15 recorded in the identical quarter within the earlier yr, FY2025. Kwality Prescription drugs Restricted’s income and internet revenue have grown at a CAGR of 21.63 % and 37.97 %, respectively, over the past 5 years.
By way of return ratios, the corporate’s ROCE and ROE stand at 18.4 % and 16.3 %, respectively. Kwality Prescription drugs Restricted has an earnings per share (EPS) of Rs. 41.8, and its debt-to-equity ratio is 0.43x.
Firm Overview
Kwality Prescription drugs Restricted was established in 1983 and is headquartered in Amritsar, India. The corporate is a outstanding pharmaceutical firm specializing within the manufacturing of advanced molecules and completed formulations. The corporate is thought for its superior manufacturing services and robust dedication to analysis and improvement.
Kwality Pharma is engaged in producing a broad vary of pharmaceutical merchandise, together with generics, cephalosporins, beta-lactams, oncology medicine, and area of interest biologics. It holds a number of international certifications resembling WHO-GMP, EU-GMP, and PIC/S, reflecting its compliance with worldwide high quality requirements.
The corporate serves markets throughout Europe, Latin America, Africa, the Center East, and Asia. The corporate’s product portfolio consists of over 3000 formulations throughout greater than 25 therapeutic areas.
Written By – Nikhil Naik
Disclaimer
The views and funding ideas expressed by funding consultants/broking homes/score businesses on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a threat of monetary losses. Traders should due to this fact train due warning whereas investing or buying and selling in shares. Commerce Brains Applied sciences Non-public Restricted or the creator will not be chargeable for any losses precipitated on account of the choice primarily based on this text. Please seek the advice of your funding advisor earlier than investing.
